Procter & Gamble Health total sale up by 3 percent at Rs 238 crores for December quarter
Mumbai: Procter & Gamble Health Limited (formerly Merck Limited) has recently announced its financial results for the half year ended December 31, 2020. The company has recorded a total sale of Rs. 238 crores for the quarter ended December 31, 2020, up 3% vs year ago. The Profit After Tax (PAT) was Rs. 68 crores vs Rs. 38 crores year ago, driven primarily by lower travel and selling...
Mumbai: Procter & Gamble Health Limited (formerly Merck Limited) has recently announced its financial results for the half year ended December 31, 2020. The company has recorded a total sale of Rs. 238 crores for the quarter ended December 31, 2020, up 3% vs year ago. The Profit After Tax (PAT) was Rs. 68 crores vs Rs. 38 crores year ago, driven primarily by lower travel and selling expenses due to Covid-19 pandemic. Sales for the six-month period ending December 31, 2020 were Rs. 496 crores, up by 10% vs year ago. Profit After Tax for same period was Rs. 127 Crore.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd